Retinal Imaging in Inherited Retinal Degenerations
This study is looking at how to better understand inherited retinal degenerations, like Retinitis Pigmentosa, which cause vision loss. Researchers are using a special camera called an Adaptive Optics Scanning Laser Ophthalmoscope (AOSLO) to take very detailed pictures of the retina (the light-sensing tissue at the back of your eye). They want to see if this camera can help them understand how these diseases affect vision. You might be able to join if you are at least 13 years old, speak English, and can travel to UC Berkeley. The study aims to measure cone spacing (the distance between light-sensing cells) after 24 months to see how the disease progresses. The current recruitment status is unclear.
- Study design
- This is an observational study, meaning researchers will observe participants without providing an intervention. The study plans to enroll up to 400 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for at least 24 months to measure cone spacing.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Retinal Imaging in Patients With Inherited Retinal Degenerations
At a glance
Conditions
NCT00254605
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Department of Ophthalmology Retinal Degenerations Clinic, UCSF
San Francisco, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jacque L. Duncan, M.D. · PRINCIPAL_INVESTIGATOR · University of California, San Francisco
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Cone spacing24 months
The current study will assess cone spacing twice at baseline and every 6 months for 30 months. The primary outcome will be measured at 24 months.